Kim Helen Susan

Director at Applied Molecular Transport Inc.; EVP, Business Development at Kite Pharma, Inc.

Sold, on record
$29.4M
Dollars the filings state
Form 4 sales
13
Latest Aug 27, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Kite Pharma, Inc.Plan not stated
    Jun 1, 2017 2017

    Sold 2,400 shares at $72.45 ($174k)

    Kim Helen Susan, EVP, Business Development

    Sold 11.4% of holdings ($1.5M position)18,664 shares left1x usual sizeFiling

  2. 2 Form 4 sale Kite Pharma, Inc.Unusual
    Jul 31, 2017 +60 days

    Sold 26,649 shares at $109.28 ($2.9M)

    Kim Helen Susan, EVP, Business Development

    Sold 58.8% of holdings ($5M position)18,664 shares left11.1x usual sizeFiling

  3. 3 Form 4 sale Kite Pharma, Inc.Unusual
    Aug 8, 2017 +8 days

    Sold 79,949 shares at $119.56 ($9.6M)

    Kim Helen Susan, EVP, Business Development

    Sold 81.1% of holdings ($11.8M position)18,664 shares left33.3x usual sizeFiling

  4. 4 Form 4 sale Kite Pharma, Inc.Unusual
    Aug 10, 2017 +2 days

    Sold 6,251 shares at $120.09 ($751k)

    Kim Helen Susan, EVP, Business Development

    Sold 25.1% of holdings ($3M position)18,664 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale Kite Pharma, Inc.Plan not stated
    Sep 25, 2017 +46 days

    Sold 3,171 shares at $179.66 ($570k)

    Kim Helen Susan, EVP, Business Development

    Sold 12.8% of holdings ($4.5M position)21,693 shares left0.5x usual sizeFiling

  6. Jul 2, 2021 +1376 days

    Sold 200,000 shares at $43.32 ($8.7M)

    Kim Helen Susan, Director

    Sold 25% of holdings ($34.7M position)600,000 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale Applied Molecular Transport Inc.Plan not stated
    Aug 25, 2021 +54 days

    Sold 9,986 shares at $30.08 ($300k)

    Kim Helen Susan, Director

    Sold 1.7% of holdings ($18M position)590,014 shares leftFiling

  8. 8 Form 4 sale Applied Molecular Transport Inc.Plan not stated
    Aug 27, 2021 +2 days

    Sold 15,014 shares at $30.20 ($453k)

    Kim Helen Susan, Director

    Sold 2.5% of holdings ($17.8M position)575,000 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Kim Helen Susan
Source
Aug 27, 2021Aug 27, 2021Applied Molecular Transport Inc.DirectorForm 4 sale15,014$453k2.5%Plan not statedSEC
Aug 25, 2021Aug 25, 2021Applied Molecular Transport Inc.DirectorForm 4 sale9,986$300k1.7%Plan not statedSEC
Jul 2, 2021Jul 6, 2021Applied Molecular Transport Inc.DirectorForm 4 sale200,000$8.7M25.0%UnusualSEC
Sep 25, 2017Sep 27, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale3,171$570k12.8%Plan not statedSEC
Aug 10, 2017Aug 14, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale6,251$751k25.1%UnusualSEC
Aug 8, 2017Aug 10, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale79,949$9.6M81.1%UnusualSEC
Jul 31, 2017Aug 1, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale26,649$2.9M58.8%UnusualSEC
Jun 1, 2017Jun 5, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale2,400$174k11.4%Plan not statedSEC
May 1, 2017May 3, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale2,400$197k11.4%Plan not statedSEC
Apr 3, 2017Apr 4, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale2,400$196k11.4%Plan not statedSEC
Mar 1, 2017Mar 2, 2017Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale50,300$3.4M72.9%UnusualSEC
Dec 20, 2016Dec 22, 2016Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale936$48k10.4%Plan not statedSEC
Aug 15, 2016Aug 16, 2016Kite Pharma, Inc.EVP, Business DevelopmentForm 4 sale35,900$2.2M80.0%UnusualSEC